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• The Philadelphia Telemedicine Glaucoma Detection and Followup Study is a CDC-funded prospective randomized controlled trial comparing a social worker intervention (enhanced intervention, EI) versus usual care (UC) in an underserved Philadelphia population.
• EI consists of telephonic outreach by a social worker to individuals with glaucoma or suspected glaucoma to address individual and systemic barriers to ophthalmology care.
• The study investigates the effect of EI on adherence to recommended follow-up eyecare in underserved Philadelphia communities (main outcome).
• In the study, health utilities are captured using the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ-25). 1 • The objective of this analysis was to report baseline utilities and assess differences in baseline utility by demographics.
• Baseline data collection took place from April 2015 through April 2017.
• Demographics were analyzed using descriptive statistics, and baseline utility scores (VFQ-UI) were derived from NEI-VFQ-25 responses using a validated algorithm. 2 o VFQ-UI is calculated from age and 6 of the 25 NEI-VFQ-25 responses. o All 7 parameters necessary to score the VFQ-UI must be present to calculate baseline utility.
• T-tests and ANOVA were used to assess statistical significance of differences in mean baseline utility by gender, race, ethnicity, marital status, and diabetic history.
• N=340 participants were included in the baseline analysis (169 UC, 171 EI).
• The mean age of the entire sample was 60.7 years (SD 11.03).
• Sample was 59.1% female and 65.0% African American.
• 55.9% reported a history of diabetes.
• Mean baseline VFQ-UI for the entire sample was 0.864 (SD 0.111). o Mean VFQ-UI for EI was 0.866 (SD 0.112) vs. 0.862 (SD 0.111) for UC; this difference was not significant (p=0.790).
• Demographics by study arm are presented in Table 1 .
• Mean VFQ-UI is generally high at baseline and did not statistically differ by study group.
• Statistically significant differences were seen by race, ethnicity, and marital status, suggesting differences in underlying health in these groups.
• Future work entails evaluating change in VFQ-UI at the 18-and 36-month follow-ups.
• Generalizability of these findings may be limited for the general US glaucoma population (more than 50% African American and recruited from the underserved in the Philadelphia area).
• Utilities could only be derived for participants that completed all six NEI-VFQ-25 subitems needed to score the VFQ-UI. o There may be selection bias resulting from exclusion of respondents with missing data.
This study was funded by the Center for Disease Control and Prevention. • No statistically significant differences were identified in the mean VFQ-UI by gender (p=0.215) or history of diabetes (p=0.604).
